1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd

000020.KS
Dongwha Pharm.Co.,LtdKR flagKorea Exchange
5,070.00
KRW
- -
- -
140.53BMarket Cap

Total Valuation

Dongwha Pharm.Co.,Ltd carries a market capitalization of 140.53B, placing it among publicly traded companies globally. Its enterprise value stands at 283.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap140.53B
Enterprise Value283.54B

Share Statistics

Dongwha Pharm.Co.,Ltd currently has 27.72M shares outstanding.

Shares Outstanding27.72M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Dongwha Pharm.Co.,Ltd trades at a trailing price-to-earnings ratio of 8.66. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 0.43.

PE Ratio8.66
PS Ratio0.32
PB Ratio0.43
P/TBV Ratio0.49
P/FCF Ratio2.73
P/OCF Ratio11.90

Enterprise Valuation

On an enterprise value basis, Dongwha Pharm.Co.,Ltd trades at an EV/EBITDA multiple of 30.77 and an EV/FCF ratio of 4.39. The EV/Sales ratio of 0.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.77 provides insight into valuation relative to core operating earnings.

EV / Sales0.57
EV / EBITDA30.77
EV / EBIT30.77
EV / FCF4.39

Financial Position

Dongwha Pharm.Co.,Ltd maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.84, indicating elevated leverage, while an interest coverage ratio of 1.84 demonstrates limited ability to service its debt obligations.

Current Ratio1.16
Quick Ratio0.11
Debt / Equity29.84
Debt / EBITDA13.26
Interest Coverage1.84

Financial Efficiency

Return on Equity (ROE)5.12
Return on Assets (ROA)2.93
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)4.26
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.90

Taxes

Over the trailing twelve months, Dongwha Pharm.Co.,Ltd has paid -886.59M in income taxes, reflecting an effective tax rate of 106.74.

Income Tax-886.59M
Effective Tax Rate106.74

Stock Price Statistics

Dongwha Pharm.Co.,Ltd's stock has declined approximately -25.55066% over the past 52 weeks. The 50-day moving average sits at 5,589.20, while the 200-day moving average is 6,029.90.

Beta (5Y)N/A
52-Week Price Change-25.55066%
50-Day Moving Average5,589.20
200-Day Moving Average6,029.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Dongwha Pharm.Co.,Ltd generated 501.33B in revenue and converted that into 18.67B in net income, yielding earnings per share of 515.51. EBITDA reached 9.22B, while operating income came in at 9.22B.

Revenue501.33B
Gross Profit223.41B
Operating Income9.22B
Pretax Income13.41B
Net Income18.67B
EBITDA9.22B
EBIT9.22B
Earnings Per Share (EPS)515.51

Balance Sheet

Dongwha Pharm.Co.,Ltd holds 22.01B in cash and equivalents against 122.24B in total debt, resulting in a net debt position of 94.97B. Total book value stands at 374.11B, with working capital of 30.89B providing operational flexibility.

Cash & Cash Equivalents22.01B
Total Debt122.24B
Net Debt94.97B
Equity (Book Value)374.11B
Book Value Per Share13,491.08
Working Capital30.89B

Cash Flow

Dongwha Pharm.Co.,Ltd produced 13.59B in operating cash flow over the past twelve months. After subtracting -45.60B in capital expenditures, free cash flow totaled -32.01B - equivalent to -1,154.34 per share.

Operating Cash Flow13.59B
Capital Expenditures-45.60B
Free Cash Flow-32.01B
FCF Per Share-1,154.34

Margins

Dongwha Pharm.Co.,Ltd operates with a gross margin of 44.56, reflecting its pricing power and cost economics. The operating margin of 1.84 and net profit margin of 3.72 provide insight into operational efficiency.

Gross Margin44.56
Operating Margin1.84
Pretax Margin2.67
Profit Margin3.72
EBITDA Margin1.84

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-7.75
FCF Yield36.61

Stock Splits

Dongwha Pharm.Co.,Ltd's most recent stock split took place on July 2, 2009 with a 1:5 split ratio.

Last Split Date7/2/2009
Split Ratio1:5

Scores

Dongwha Pharm.Co.,Ltd posts an Altman Z-Score of 2.27, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.27